Brief: Supriya Lifescience Completion Of WHO Gmp Audit At Ambernath Facility
01/10/2025 11:51
Oct 1 (Reuters) - Supriya Lifescience SPRL.NS: COMPLETION OF WHO GMP AUDIT AT AMBERNATH FACILITY WHO ISSUES WHO-GMP CERTIFICATE FOR AMBERNATH FACILITY Source text: ID:nBSEbwl5Z7 Further company coverage: SPRL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit